Publication | Closed Access
LBA11 Individual patient data meta-analysis of 5 non-inferiority RCTs of reduced duration single agent adjuvant trastuzumab in the treatment of HER2 positive early breast cancer
24
Citations
0
References
2021
Year
Breast OncologyMedicineImmunologyBreast CancerNon-inferiority RctsCancer TreatmentOncologyRadiation Oncology
No additional data available for this publication yet. Check back later!